378 related articles for article (PubMed ID: 36428707)
1. Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer.
Haque E; Esmail A; Muhsen I; Salah H; Abdelrahim M
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428707
[TBL] [Abstract][Full Text] [Related]
2. Gastric Cancer: Molecular Mechanisms, Novel Targets, and Immunotherapies: From Bench to Clinical Therapeutics.
Baccili Cury Megid T; Farooq AR; Wang X; Elimova E
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894443
[TBL] [Abstract][Full Text] [Related]
3. Application of immune checkpoint inhibitors in immunotherapy for gastric cancer.
Wu YX; Zhou XY; Wang JQ; Chen GM; Chen JX; Wang RC; Huang JQ; Chen JS
Immunotherapy; 2023 Feb; 15(2):101-115. PubMed ID: 36597704
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in gastric cancer.
Matsueda S; Graham DY
World J Gastroenterol; 2014 Feb; 20(7):1657-66. PubMed ID: 24587645
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer treatment: recent progress and future perspectives.
Guan WL; He Y; Xu RH
J Hematol Oncol; 2023 May; 16(1):57. PubMed ID: 37245017
[TBL] [Abstract][Full Text] [Related]
6. Gastric Cancer: Emerging Trends in Prevention, Diagnosis, and Treatment.
Norwood DA; Montalvan-Sanchez E; Dominguez RL; Morgan DR
Gastroenterol Clin North Am; 2022 Sep; 51(3):501-518. PubMed ID: 36153107
[TBL] [Abstract][Full Text] [Related]
7. Emerging Opportunities and Challenges in Cancer Immunotherapy.
Whiteside TL; Demaria S; Rodriguez-Ruiz ME; Zarour HM; Melero I
Clin Cancer Res; 2016 Apr; 22(8):1845-55. PubMed ID: 27084738
[TBL] [Abstract][Full Text] [Related]
8. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.
Shah SC; Piazuelo MB; Kuipers EJ; Li D
Gastroenterology; 2021 Oct; 161(4):1325-1332.e7. PubMed ID: 34454714
[TBL] [Abstract][Full Text] [Related]
9. Brain Metastases: A Modern Multidisciplinary Approach.
O'Halloran PJ; Gutierrez E; Kalyvas A; Mohan N; Atallah S; Kalia S; Millar BA; Laperriere N; Conrad T; Zadeh G; Bernstein M; Shultz DB; Kongkham P
Can J Neurol Sci; 2021 Mar; 48(2):189-197. PubMed ID: 33040758
[TBL] [Abstract][Full Text] [Related]
10. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of gastric cancer: Past, future perspective and challenges.
Xie J; Fu L; Jin L
Pathol Res Pract; 2021 Feb; 218():153322. PubMed ID: 33422778
[TBL] [Abstract][Full Text] [Related]
12. HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies.
Pous A; Notario L; Hierro C; Layos L; Bugés C
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511163
[TBL] [Abstract][Full Text] [Related]
13. Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.
Park R; Williamson S; Kasi A; Saeed A
Anticancer Res; 2018 Oct; 38(10):5569-5580. PubMed ID: 30275174
[TBL] [Abstract][Full Text] [Related]
14. Emerging Trends in Immunotherapy for Cancer.
Mishra AK; Ali A; Dutta S; Banday S; Malonia SK
Diseases; 2022 Sep; 10(3):. PubMed ID: 36135216
[TBL] [Abstract][Full Text] [Related]
15. Advances in clinical immunotherapy for gastric cancer.
Li K; Zhang A; Li X; Zhang H; Zhao L
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188615. PubMed ID: 34403771
[TBL] [Abstract][Full Text] [Related]
16. Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials.
Lote H; Chau I
Expert Opin Investig Drugs; 2022 Jan; 31(1):59-78. PubMed ID: 35034511
[TBL] [Abstract][Full Text] [Related]
17. Current status of treatment with immune checkpoint inhibitors for gastrointestinal, hepatobiliary, and pancreatic cancers.
Eso Y; Seno H
Therap Adv Gastroenterol; 2020; 13():1756284820948773. PubMed ID: 32913444
[TBL] [Abstract][Full Text] [Related]
18. Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer.
Xu D; Luo Y; Wang P; Li J; Ma L; Huang J; Zhang H; Yang X; Li L; Zheng Y; Fang G; Yan P
Front Oncol; 2023; 13():1148131. PubMed ID: 37384288
[TBL] [Abstract][Full Text] [Related]
19. Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy.
Cai H; Li M; Deng R; Wang M; Shi Y
Biomark Res; 2022 Aug; 10(1):67. PubMed ID: 36042469
[TBL] [Abstract][Full Text] [Related]
20. Current Development of Monoclonal Antibodies in Cancer Therapy.
Parakh S; King D; Gan HK; Scott AM
Recent Results Cancer Res; 2020; 214():1-70. PubMed ID: 31473848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
